Ofev Less Beneficial for Patients with Severe IPF

This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 10 months, 1 week ago.

  • Author
    Posts
  • #15247

    A recent study found that that treatment with Ofev offers fewer clinical benefits to patients with severe idiopathic pulmonary fibrosis (IPF). Click here to find out more.

    Have you been treated with Ofev? Do you think the severity of your diagnosis impacted its ability to help you?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account